Home » Topics » BioWorld Science

BioWorld Science
RSS

BRAF fusion drug responses diverse but predictable

Oct. 22, 2019

Metabolic problems are early event in Alzheimer's

Oct. 22, 2019

Proof of concept of PRIT in peritoneal carcinomatosis presented

Oct. 22, 2019

Primary endpoint met in HER2CLIMB trial of tucatinib in HER2-positive breast cancer

Oct. 21, 2019

FDA grants approval to Amzeeq topical foam for acne

Oct. 21, 2019

FDA approves Farxiga to reduce risk of hospitalization for heart failure in type 2 diabetes patients

Oct. 21, 2019

Ultomiris approved in U.S. for atypical hemolytic uremic syndrome

Oct. 21, 2019

Xuzhou Medical University describes CAR-T therapy targeting HBVsAg

Oct. 21, 2019

Phase II study of CV-301 in bladder cancer does not meet efficacy threshold to progress

Oct. 21, 2019

IMbrave150 study of Tecentriq with Avastin in HCC meets coprimary endpoints

Oct. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...